AtriCure, Inc. (ATRC) key performance indicators and operating metrics (16 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 17.09M | FY2026-Q1 |
| Revenue (International) | 25.04M | FY2026-Q1 |
| Revenue (United States) | 116.21M | FY2026-Q1 |
| Appendage Management Revenue (United States) | 48.38M | FY2026-Q1 |
| Minimally Invasive Ablation Revenue (United States) | 6.39M | FY2026-Q1 |
| Open Ablation Revenue (United States) | 39.08M | FY2026-Q1 |
| Pain Management Revenue (United States) | 22.36M | FY2026-Q1 |
| Appendage Management Revenue (International) | 11.63M | FY2026-Q1 |
| Open Ablation Revenue (International) | 9.52M | FY2026-Q1 |
| Pain Management Revenue (International) | 1.99M | FY2026-Q1 |
| Minimally Invasive Ablation Revenue (International) | 1.91M | FY2026-Q1 |
| Worldwide Revenue Guidance | 141.22M | FY2026-Q1 |
| Adjusted Loss per Share Outlook | -0.01 USD_per_share | FY2025-Q3 |
| Adjusted Loss per Share | -0.02 USD_per_share | FY2025-Q2 |
Back to ATRC overview · ATRC earnings · ATRC holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.